...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: My hunch... It's hepalink
This new scaffold of cutting edge epignetics is to exciting for bilionaire Li of Shenzhen Hepalink Pharmaceutical to sit idly by... He's already sitting on 35 million dollars of parent company . Using the same design of purchase hepalink I believe will be willing to fund zenith ltd the same way including trials in the territories Adding further value to both companies , just my two pennies ... Stock ,
Share
New Message
Please login to post a reply